What is postpartum HELLP syndrome?

What is Postpartum HELLP Syndrome?

Postpartum HELLP syndrome is a life-threatening obstetric emergency occurring after delivery, characterized by the triad of Hemolysis, Elevated Liver enzymes, and Low Platelets—representing the most severe end of the preeclampsia spectrum that can develop even when antepartum signs were minimal or absent. 1

Definition and Pathophysiology

HELLP syndrome is fundamentally a severe variant of preeclampsia with multisystem involvement. The acronym stands for:

• Hemolysis (microangiopathic hemolytic anemia)
• ELevated Liver enzymes (hepatocellular injury)
• LPLow Platelets (thrombocytopenia)

Postpartum HELLP specifically occurs after delivery, accounting for approximately 30% of all HELLP cases, with the majority (70%) developing antepartum. 2 Importantly, neurological manifestations may precede the full biochemical expression of the syndrome. 3

Clinical Presentation

Cardinal Symptoms

The clinical presentation includes:

• Epigastric or right upper quadrant pain (most common presenting symptom)
• Upper abdominal tenderness
• Nausea and vomiting
• Proteinuria
• Hypertension (though may be absent initially)
• Jaundice
• Severe headache and visual disturbances 1

Timing

Neurological manifestations typically occur within 48 hours postpartum, though the full laboratory criteria may not yet be present at symptom onset. 3

Diagnostic Criteria

Laboratory Diagnosis

The diagnosis is confirmed by laboratory investigations showing:

• Hemolysis: Evidence on peripheral blood smear, elevated lactate dehydrogenase, elevated bilirubin
• Elevated liver enzymes: Increased AST/ALT concentrations
• Thrombocytopenia: Platelet count < 100,000/mm³ 1

Classification System

HELLP can be classified as:

• Complete: All three criteria present
• Incomplete: Only one or two criteria present
• Class I: Platelets < 50,000/mm³
• Class II: Platelets 50,000-100,000/mm³
• Class III: Platelets > 100,000/mm³ 4

The degree of thrombocytopenia correlates directly with the severity of liver dysfunction. 1

Life-Threatening Complications

Maternal Morbidity and Mortality

Maternal mortality is approximately 1.1%, but postpartum HELLP carries significantly higher risk for specific complications compared to antepartum cases. 2

Critical complications include:

• Disseminated intravascular coagulation (21%)—strongly correlated with abruptio placentae
• Abruptio placentae (16%)
• Acute renal failure (7.7%)—significantly more common in postpartum cases
• Pulmonary edema (6%)—significantly more common in postpartum cases and strongly associated with renal failure
• Subcapsular liver hematoma/rupture (0.9%)—rare but catastrophic
• Adult respiratory distress syndrome
• Retinal detachment (0.9%)
• Posterior reversible encephalopathy syndrome (PRES)—may precede full biochemical diagnosis 1, 3, 2

There is a strong association between pulmonary edema and acute renal failure (p < 0.0001), and both occur more frequently in postpartum HELLP. 2

Transfusion Requirements

Approximately 55% of patients require blood or blood product transfusions, and 2% require emergency laparotomy for major intraabdominal bleeding. 2

Critical Diagnostic Pitfalls

Misdiagnosis Risk

Non-obstetric diagnoses are frequently considered initially, including:

• Acute cholecystitis
• Drug reaction
• Idiopathic thrombocytopenia
• Viral hepatitis 1

Anemia Source Confusion

A critical challenge is differentiating rapid hemoglobin drop from hemolysis versus postpartum hemorrhage—both can coexist, and HELLP-associated coagulopathy can cause diffuse bleeding without an isolated source. 5

Neurological Symptoms Before Laboratory Confirmation

PRES and eclamptic seizures may occur before laboratory values meet full HELLP criteria, requiring high clinical suspicion and early neuroimaging. 3

Management Principles

Immediate Actions

The only definitive treatment is delivery (for antepartum cases), but postpartum HELLP requires aggressive supportive management:

• Blood pressure control: IV hydralazine or magnesium sulfate to prevent eclampsia and intracranial hemorrhage
• Seizure prophylaxis: Magnesium sulfate
• Platelet transfusion: Recommended if count < 50,000/mm³, especially before surgical intervention
• Fresh frozen plasma: For coagulopathy
• Blood transfusion: If hemoglobin < 10 g/dL 1

Monitoring Requirements

Intensive monitoring in high-dependency or ICU setting for at least 24 hours postpartum includes:

• Central venous pressure (many patients are relatively hypovolemic)
• Hourly urinary output via catheter
• Non-invasive blood pressure
• ECG and oxygen saturation
• Serial laboratory assessments (platelets, liver enzymes, hemolysis markers, coagulation studies)
• Maternal blood glucose (severe hypoglycemia reported) 1

Advanced Interventions

For severe cases:

• Corticosteroids: May accelerate recovery
• Plasmapheresis: For refractory cases
• Antifibrinolytic therapy (tranexamic acid): For hyperfibrinolysis in DIC context
• Renal replacement therapy: For acute renal failure 3, 5

Natural History and Recovery

In the majority of cases, the condition resolves within days after delivery, with platelet counts typically recovering by postpartum day 2-3 and liver enzymes normalizing over the following week. 1 However, postpartum cases demonstrate higher rates of pulmonary edema and renal failure despite similar laboratory findings to antepartum cases. 2

Long-Term Implications

HELLP syndrome is associated with increased risk of developing cardiovascular, metabolic, and neurological diseases in later life, requiring long-term follow-up and risk factor modification. 6